PostEra offers medicinal chemistry powered by machine learning. Drug discovery R&D is slow and expensive and this limits biotechs and pharma from getting new drugs into development and new cures to patients. PostEra is building an end-to-end med chem platform to advance drug discovery and serve the world's ever expanding community of drug hunters. We've raised $26M from top tech/healthcare investors and [signed](https://endpts.com/a-new-ai-startup-has-emerged-and-pfizer-likes-what-it-sees/) large multi-year deals with companies like Pfizer.